Life Science Leader Magazine Supplements

CRO Supplement 2015

The vision of Life Science Leader is to help facilitate connections and foster collaborations in pharma and med device development to get more life-saving and life-improving therapies to market in an efficient manner. Connect, Collaborate, Contribute

Issue link: https://lifescienceleadermag.epubxp.com/i/503574

Contents of this Issue

Navigation

Page 38 of 51

QUALITY RELIABILITY PRODUCTIVITY REGULATORY INNOVATION K E Y W W W.C R O L E A D E R S H I PA W A R D S .C O M 2015 CRO LEADERSHIP AWARDS WINNERS Company Profiles LIFESCIENCELEADER.COM THE CRO LEADERSHIP AWARDS 2015 39 Charles River Wilmington, MA www.criver.com +1 781 222 6000 +1 877 CRiver1 askcharlesriver@crl.com Key locations: Canada, France, Germany, Ireland, Italy, Japan, United Kingdom, United States DRUG LIFE CYCLE STAGES: Research & Development: Clinical (Phase 1, Phase 2) DRUG LIFE CYCLE STAGES: Research & Development: Discovery, Preclinical, Clinical (Phase 1, Phase 2, Phase 3), Manufacturing Support DRUG LIFE CYCLE STAGES: Research & Development: Clinical (Phase 1, Phase 2, Phase 3) MAIN SERVICE AREAS: Lab, Full Service Clinical MAIN SERVICE AREAS: Preclinical, Lab MAIN SERVICE AREAS: Full Service Clinical "Our mission has always been to provide the highest quality early stage clinical development solutions, while exceeding our customers' expec- tations with personalized and timely service. These awards recognize and validate the efforts our employees put in on a daily basis to achieve our goal. To be recognized by our clients in such a way is both rewarding and a phenomenal success story for us." "I am pleased that our clients recognize Charles River's industry leadership with this award. Our portfolio is the strongest it has ever been, with the ability to support clients from target discovery through preclinical development. We have deep client relationships, where we are a respected and trusted partner; a streamlined organization, with the flexibility to respond to a changing industry and client requirements; and employees who are committed to providing exceptional service ." "Chiltern's approach is one of leading by listening and then applying our experience and skill to develop a customized solution. We work on a flexible platform where our employees are encouraged to be creative and service-oriented to meet client requirements. Chiltern creates an engagement that is truly unique to customer requirements; be that an individual study, a full clinical program, a single CRA, or an entire biometrics function. Our services are 'Designed Around You.'" SERVICES & CAPABILITIES: Full-service offering focused on early stage clinical development: design and conduct of Phase I/IIa trials, large and small molecule bioanalysis, data management, biostatistics, regulatory support, clinical pharmacology, and project management THERAPEUTIC AREAS: Algorithme Pharma provides research services to the pharmaceutical, generic, and biotechnology industries, with particular expertise in metabolic disease, nephrology, inflammation, hormone therapy, and infectious disease. SERVICES & CAPABILITIES: Discovery services, research models and services, safety assessment, laboratory and pathology support, agrochemical and animal health product development, biologics testing solutions, endotoxin and microbial d etection THERAPEUTIC AREAS: Cardiovascular, endocrine/metabolic, oncology, skeletal disease, central nervous system, inflammation, ophthalmology, and vaccines/cell therapy/ b iosimilars SERVICES & CAPABILITIES: Project management, clinical monitoring, regulatory affairs, medical monitoring, data manageme nt, biostatistics, pharmacovigilance, medical writing, activate study startup, eClinical, database programming, resourcing, QA, late phase, functional service provider, and interactive response technology THERAPEUTIC AREAS: Oncology, anti-infectives, vaccines, ophthalmology, dermatology, respiratory, rheumatology, inflammation, hematology, and g astroenterology CHRIS PERKIN president & CEO JAMES C. FOSTER chairman, president and CEO DR. JIM ESINHART CEO CATEGORIES WON CATEGORIES WON CATEGORIES WON Chiltern Slough, Berkshire, United Kingdom www.chiltern.com +1 910 338 4760 or +44 1753 512 000 Nicholas Spittal lets.talk@chiltern.com Key locations: U nited States, United Kingdom, Western Europe, Central and Eastern Europe, Latin America, Asia-Pacific, MENA Algorithme Pharma Laval, Qu├ębec, Canada www.algopharm.com +1 450 973 6077 Catherine Konidas ckonidas@algopharm.com

Articles in this issue

Links on this page

Archives of this issue

view archives of Life Science Leader Magazine Supplements - CRO Supplement 2015